New Horizon Health Ltd
HKEX:6606

Watchlist Manager
New Horizon Health Ltd Logo
New Horizon Health Ltd
HKEX:6606
Watchlist
Price: 14.14 HKD Market Closed
Market Cap: HK$6.3B

New Horizon Health Ltd
Investor Relations

New Horizon Health Ltd. operates as an investment holding company. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-02-18. The firm distributes its ColoClear, Pupu tube and other products to customers through its own network, contracted sales organisations (CSOs) and Internet sales or e-platform operated by healthcare clinics. The Company’s Youyou Tube (a stool-based self-checking gastric cancer screening test) and CerviClear (a non-invasive urine cervical cancer home screening test) are under development.

Show more
Loading
6606
Hang Seng (Hong Kong)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Yeqing Zhu
CEO, Executive Chairman & Co-founder
No Bio Available
Dr. Yiyou Chen Ph.D.
Executive Director & Chief Scientific Officer
No Bio Available
Mr. Yu Gao
CFO & Joint Company Secretary
No Bio Available
Dr. Ning Lu
Chief Technology Officer
No Bio Available
Ms. Ming-Wai Mok
Joint Company Secretary
No Bio Available

Contacts

Address
ZHEJIANG
Hangzhou
13/F, T1 Building, 400 Jiang'er Road, Binjiang District
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett